Latest Breaking News On - Orphan product development - Page 2 : comparemela.com

Jazz Pharmaceuticals Showcases Impact of Sleep Medicine Portfolio at Psych Congress 2023

/PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that six abstracts presenting data from across its sleep medicine portfolio were.

United statesUniversity of south carolinaSouth carolinaRichardk boganAndrean flynnKelvin tanKristin bhavnaniPsych congressWorld idiopathic hypersomnia total health modelUnmet public health problemIndian journal of medical researchAmerican psychiatric associationNational health serviceNational institute of neurological disordersAmerican academy of sleep medicineHead of global corporate communications

Avadel to Unveil New Data on Lumryz for Narcolepsy Treatment

Avadel Pharmaceuticals will present new data supporting the clinical profile for Lumryz for narcolepsy in 12 abstracts at SLEEP 2023.

United statesJennifer gudemanClete kushidaYves dauvilliersMichaelj thorpyAnne marie morseStanford centerStanford university medical centerAlbert einstein college of medicineOffice of orphan product developmentAmerican academy of sleepWake disorders center at montefioreAvadel pharmaceuticalsWake disorders centreDrug administrationHuman sleep research at stanford university

Jazz Pharmaceuticals Demonstrates Continued Leadership in Sleep Medicine with New Data Presentations at SLEEP 2023

/PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that seven abstracts featuring new data from across its sleep medicine portfolio will.

United statesKelvin tanAndrean flynnKristin bhavnaniHead of global corporate communicationsJazz pharmaceuticalsDrug enforcement agencyUnited states drug enforcement agencyAmerican academy of sleep medicineDrug administrationInternational classification of sleep disordersNational institute of neurological disordersOffice of orphan product developmentNational academies pressJazz pharmaceuticals incWorld idiopathic hypersomnia total health

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Demonstrates Continued Leadership in Sleep Medicine with New Data Presentations at SLEEP 2023

Seven abstracts emphasize Jazz's commitment to advancing the care and understanding of debilitating sleep disorders such as narcolepsy and idiopathic hypersomnia DUBLIN, May 31, 2023 /PRNewswire/

United statesAndrean flynnKelvin tanKristin bhavnaniInternational classification of sleep disordersDrug administrationUnmet public health problemJazz pharmaceuticalsAmerican academy of sleep medicineAmerican psychiatric associationWorld idiopathic hypersomnia total healthPrnewswire jazz pharmaceuticalsNational academies pressNational health serviceIndian journal of medical researchUs drug enforcement agency

Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ at SLEEP 2023

Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ at SLEEP 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLois krahnMichaelj thorpyMatthew horsnellMelissa lipfordMaurice ohayonMichael thorpyAnne marie morseYves dauvilliersClete kushidaThomas rothJennifer gudemanResearch societyDepartment of neurologyClinical affairs of avadelWake disorders centre